MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aldeyra Therapeutics Company Profile (NASDAQ:ALDX)

Consensus Ratings for Aldeyra Therapeutics (NASDAQ:ALDX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.50 (140.46% upside)

Analysts' Ratings History for Aldeyra Therapeutics (NASDAQ:ALDX)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015Canaccord GenuityReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015HC WainwrightLower Price TargetBuy$14.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Chardan CapitalInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015LaidlawInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014Ascendiant Capital MarketsInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2014AegisInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha